Evidence map›Paper›PMID 33918552›Full record

ArticleJournal of clinical medicine2021

Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?

Jose Enrique de la Rubia Ortí, Jose Luis Platero Armero, Claudia Emmanuela Sanchis-Sanchis, Sandra Sancho-Castillo, Alejandro Salazar, Jordi Caplliure-Llopis, Esther Navarro-Illana, Carlos Barrios, Jesús Escribá-Alepuz, María Benlloch

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jose Enrique de la Rubia OrtíDepartment of Basic Medical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.ORCID 0000-0001-6808-9505
Jose Luis Platero ArmeroDepartment of Basic Medical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.
Claudia Emmanuela Sanchis-SanchisDepartment of Basic Medical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.ORCID 0000-0002-2660-5505
Sandra Sancho-CastilloDepartment of Basic Medical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.
Alejandro SalazarDepartment of Statistics and Operational Research, University of Cádiz, Puerto Real, 11510 Cádiz, Spain.ORCID 0000-0001-9567-462X
Jordi Caplliure-LlopisDoctoral Degree's School, Catholic University of Valencia, 46001 Valencia, Spain.ORCID 0000-0001-7361-3885
Esther Navarro-IllanaDepartment of Basic Medical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.
Carlos BarriosInstitute for Research on Musculoskeletal Disorders, Valencia Catholic University, 46001 Valencia, Spain.ORCID 0000-0002-6657-7246
Jesús Escribá-AlepuzNeurophysiology Department, Sagunto University Hospital, 46520 Valencia, Spain.ORCID 0000-0002-4197-3293
María BenllochDepartment of Basic Medical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.ORCID 0000-0002-3342-6732
Universitat de València · ESHospital de Sagunto · ESUniversidad de Cádiz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the pathogenic mechanisms of ALS disease is perturbed energy metabolism particularly glucose metabolism. Given the substantial difference in the severity and the prognosis of the disease, depending on whether it has a bulbar or spinal onset, the aim of the study was to determine metabolic differences between both types of ALS, as well as the possible relationship with muscle function. MATERIALS AND

methodsA descriptive, analytical, quantitative, and transversal study was carried out in hospitals and Primary Care centers in the region of Valencia, Spain. Fasting glucose and alkaline phosphatase (AP) levels in venous blood, muscle percentage, fat percentage, muscle strength (MRC scale), and functional capacity (Barthel Index) were measured in 31 patients diagnosed with ALS (20 with spinal onset ALS and 11 with bulbar onset ALS). A healthy control of 29 people was included.

resultsNo significant differences were observed in blood AP and glucose levels between spinal onset and bulbar onset ALS patients. However, a significant positive correlation was observed between the mean values of both substances in patients with spinal onset ALS. Moreover, a lower percentage of muscle mass and a higher percentage of fat mass were also seen in spinal ALS patients, who also presented lower muscle strength and lower functional capacity.

conclusionThe results of this study seem to point to a possible difference in the peripheral use of glucose between patients with bulbar onset ALS and spinal onset ALS, who appear to have possible insulin resistance. These metabolic differences could explain the lower muscle percentage and lower muscular function in spinal onset ALS patients, although further studies are required.

Indexed as

alkaline phosphataseamyotrophic lateral sclerosisbulbar onset ALSglucosespinal onset ALS

Identifiers

PMID33918552
PMCPMC8069029
OpenAlexW3156893087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.